Phenotype-driven genetic approaches in mice: high-throughput phenotyping for discovering new models of cardiovascular

B D Hoit1, J H Nadeau

  • 1Department of Medicine, Case Western Reserve University School of Medicine, 10900 Euclid Ave., Cleveland, OH 44106, USA. bdh6@po.cwru.edu

Insights

Understanding the genetic basis of cardiovascular diseases, from simple Mendelian traits to complex polygenic and multifactorial conditions, is key. This knowledge can improve diagnosis, treatment, and our understanding of heart health.

Area of Science:

  • Genetics
  • Cardiovascular Medicine
  • Human Physiology

Background:

  • Cardiovascular diseases (CVDs) like hypertension and atherosclerosis incur significant health and economic burdens.
  • While some CVDs are Mendelian, most are genetically complex, involving multiple genes or gene-environment interactions.
  • Understanding the genetic architecture of CVDs is crucial for advancing medical science.

Purpose of the Study:

  • To explore the genetic underpinnings of cardiovascular diseases.
  • To highlight the potential of genetic insights for improved diagnostic and therapeutic strategies.
  • To deepen the fundamental understanding of cardiovascular physiology through genetic research.

Main Methods:

  • Review of genetic principles applicable to complex diseases.
  • Analysis of genetic factors in conditions like hypertension, atherosclerosis, cardiac hypertrophy, homocysteinemia, and arrhythmias.
  • Integration of knowledge on polygenic, epistatic, and multifactorial inheritance patterns.

Main Results:

  • Cardiovascular diseases exhibit a spectrum of genetic complexity, ranging from single-gene disorders to intricate polygenic and multifactorial conditions.
  • Genetic factors play a significant role in the etiology and progression of various cardiovascular diseases.
  • Environmental interactions significantly influence the manifestation of genetically complex cardiovascular conditions.

Conclusions:

  • Elucidating the genetic control of cardiovascular diseases offers a pathway to enhanced diagnostic accuracy.
  • Genetic insights can drive the development of novel and personalized treatment approaches for cardiovascular conditions.
  • Further research into the genetics of CVDs promises to advance basic physiological understanding and clinical practice.

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...